Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Monash IVF GroupASX:MVF -2.14%82 EV-to-OCF is 17.71 as of Aug. 09, 2026, which is 35% above its 10-year median of 13.08. GuruFocus rates ASX:MVF with a GF Score™ of 82/100 and a GF Value™ of A$1.41 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 213 Medical Diagnostics & Research companies, Monash IVF Group ranks worse than 71.36% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Monash IVF Group's Enterprise Value is A$460.5 Mil.
Monash IVF Group's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was A$26.0 Mil. Therefore, Monash IVF Group's EV-to-OCF for today is 17.71.
The historical rank and industry rank for Monash IVF Group's EV-to-OCF or its related term are showing as below:
ASX:MVF'
s EV-to-OCF Range Over the Past 10 Years
Min: 5.5 Med: 13.08 Max: 39.21
Current: 17.71
During the past 12 years, the highest EV-to-OCF of Monash IVF Group was 39.21. The lowest was 5.50. And the median was 13.08.
ASX:MVF's EV-to-OCF is ranked worse than 71.36% of 213
companies
in the Medical Diagnostics & Research industry
Industry Median: 6.35
vs ASX:MVF: 17.71
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Monash IVF Group's PE Ratio (TTM) for today is calculated as:
Monash IVF Group's share price for today is A$0.685.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Monash IVF Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.038.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Monash IVF Group EV-to-OCF Related Terms
Monash IVF Group EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Monash IVF Group's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Monash IVF Group's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Monash IVF Group EV-to-OCF vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Monash IVF Group's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Monash IVF Group's EV-to-OCF falls into.
Monash IVF Group's current Enterprise Value is A$460.5 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Monash IVF Group's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was A$26.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Monash IVF Group (ASX:MVF) has a EV-to-OCF of 17.71 as of Aug. 09, 2026. This is 35% above median its historical median of 13.08. Over the past decade, Monash IVF Group's EV-to-OCF has ranged from 5.50 to 39.21. According to the industry distribution chart, Monash IVF Group ranks #152 out of 213 companies in the Medical Diagnostics & Research industry, placing it in the top 71.4%.
Is Monash IVF Group's EV-to-OCF too high?
Monash IVF Group's current EV-to-OCF of 17.71 is 35% above median its 10-year median of 13.08. Over the past 10 years, this metric has ranged from a low of 5.50 to a high of 39.21. The Medical Diagnostics & Research industry median EV-to-OCF is 6.35. Monash IVF Group's value of 17.71 is 178.9% above this industry median. Based on the distribution chart, Monash IVF Group ranks #152 out of 213 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Monash IVF Group has a GF Score™ of 82/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Monash IVF Group's EV-to-OCF compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Monash IVF Group ranks #152 out of 213 companies for EV-to-OCF. This places Monash IVF Group in the lower half of its industry. The industry median EV-to-OCF is 6.35. Monash IVF Group's value of 17.71 is 178.9% above this benchmark. Historically, Monash IVF Group's own EV-to-OCF has ranged from 5.50 to 39.21 over the past decade. While the company's 10-year median is 13.08 vs. the industry median of 6.35, Monash IVF Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Diagnostics & Research company?
The median EV-to-OCF among Medical Diagnostics & Research companies is 6.35, based on 213 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Monash IVF Group's current EV-to-OCF of 17.71 is 178.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Diagnostics & Research industry, the median EV-to-OCF is 6.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Monash IVF Group's current EV-to-OCF is 17.71, which is 35% above median its own 10-year median of 13.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Monash IVF Group stock overvalued right now?
Based on GuruFocus' analysis, Monash IVF Group (ASX:MVF) is currently considered Possible Value Trap. The stock's GF Value™ is A$1.41, compared to a current price of A$0.69 — trading 51.4% below its estimated fair value. The current EV-to-OCF is 17.71, which is 35% above median its 10-year median of 13.08 and 178.9% above the Medical Diagnostics & Research industry median of 6.35. Monash IVF Group's overall GF Score™ is 82/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Monash IVF Group (ASX:MVF), the current EV-to-OCF is 17.71 as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Monash IVF Group (ASX:MVF) Overvalued in 2026?
Based on GuruFocus' analysis, Monash IVF Group stock appears to be undervalued.
The current stock price of A$0.69 is trading 51.4% below its estimated GF Value™ of A$1.41.
GuruFocus considers Monash IVF Group to be Possible Value Trap.
Key valuation signals for ASX:MVF:
EV-to-OCF: 17.71 (35% above median its 10-year median of 13.08)
GF Value™: A$1.41 vs. price of A$0.69 (51.4% below fair value)
Industry Position: 178.9% above the Medical Diagnostics & Research median (#152 of 213)
No single metric tells the full story. See the ASX:MVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Monash IVF Group Ltd is a provider of fertility services, specializing in Assisted Reproductive Services (ARS) and genetic care across Australia and South East Asia. The Group operates two main segments: Australia IVF and Ultrasound, which offer ARS, ultrasound, and related women's health services, and International IVF, which provides assisted reproductive care in South East Asia. The majority of revenue is generated from the Australian segment through its brands such as Fertility Solutions, KL Fertility, Monash IVF, Repromed, and others.
82GF Score
Get the complete analysis for ASX:MVF
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:MVF has been successfully added to your 
